Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Italy

Marie Skłodowska-Curie Action · Running

INTELLI-INGEST Intelligent Ingestible Devices for Gastrointestinal Therapeutics, Diagnosis or Intervention.

Coordinator
Scuola Superiore Di Studi Universitari E Di Perfezionamento S Anna, Italy
Runs
1 March 2025 to 28 February 2029
Status
Running
EU funding
€2.7m
Total cost
—
Partners
11 organisations in 7 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101169012

What the project is doing

In the project's own words, from its summary on CORDIS.

The Intelli-Ingest Doctoral Network will train 13 researchers in the development of minimally invasive, orally delivered miniaturised devices. This ingestible technology has the potential to unlock significant advances across the medical sciences, whether it is enhanced diagnosis through the application of artificial intelligence or the integration of multiple sensors into these devices, surgery through less invasive biopsy or treatment through targeted drug delivery direct to the site of interest or the development of therapeutic form factors that can safely reside within the gastrointestinal tract for extended periods, removing the need for daily treatment and improving the adherence of patients to the treatment regimen.

However, to achieve this potential, several scientific challenges must be addressed. These include needing more accurate localisation, improving our ability to know where the devices are along the gastrointestinal tract at any time for better treatment and repeated diagnosis. The second challenge is the need to integrate more advanced diagnostic and therapeutic technology, which is vital for more accurate identification and treatment of pathology.

The third challenge is environmental sustainability; more sustainable designs are crucial due to the single-use nature of most ingestible devices and their growing use post-pandemic. Finally, to rapidly innovate in the ingestible device field, we need better tools to advance translation at low cost, reducing the use of costly animal models. The 13 doctoral candidates will tackle these challenges, advancing the state of the art in ingestible device technology while benefiting from multidisciplinary, multi-sectoral, international training provided by leaders in this field.

This training will provide these candidates with extensive technical, translational and transferable skills training that will enhance their future career prospects in this growing field of research.

Topics

Who is involved

OrganisationCityCountryRole
Scuola Superiore Di Studi Universitari E Di Perfezionamento S AnnaPisaItalyCoordinator
Ovesco Endoscopy AGTubingenGermanyAssociatedpartner
Danmarks Tekniske UniversitetKongens LyngbyDenmarkParticipant
Mycro3D ApSKongens LyngbyDenmarkAssociatedpartner
Region SyddanmarkVejleDenmarkAssociatedpartner
Panepistimio ThessaliasVolosGreeceParticipant
BodycapHérouville St ClairFranceAssociatedpartner
Centre National De La Recherche Scientifique CNRSParisFranceParticipant
Universite De RennesRennesFranceAssociatedpartner
Biocam sp z o.oKrzykówPolandAssociatedpartner
The University of BirminghamBirminghamUnited KingdomAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI